Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Place any order that is greater than $500 and get a mystery box from ACROBiosystems!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CA9-H5220 | Human | Human Carbonic Anhydrase IX / CA9 (138-414) Protein, His Tag | ![]() |
![]() ![]() |
|
CA9-H5226 | Human | Human Carbonic Anhydrase IX / CA9 (38-414) Protein, His Tag (active enzyme) | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
PMI-05 | PMI-05 | Phase Ⅰ | Precision Molecular | Cancer | Details |
Monoclonal antibody G250RIT | Phase Ⅱ | Janssen, Wilex | Renal carcinoma, Biliary cancer | Details | |
Lutetium-177 DOTA girentuximab | Phase Ⅱ | Telix Pharmaceuticals, Wilex, Heidelberg | Clear cell renal cell cancer (ccRCC) | Details | |
Indium-111-DOTA-girentuximab-IRDye800CW (Radboud University) | Phase Ⅰ | Radboud University | Renal cell carcinoma, Diagnostic agents | Details | |
99mTc-MIP-1490 (Molecular Insight Pharmaceuticals) | 99mTc-MIP-1490 | Phase Not Specified | Progenics Pharmaceutical | Cancer | Details |
99mTc-MIP-1504 (Molecular Insight Pharmaceuticals) | 99mTc-MIP-1504 | Phase Not Specified | Progenics Pharmaceutical | Cancer | Details |
G250-scFV-transduced autologous T-lymphocyte cell therapy (Daniel den Hoed Cancer Center) | Phase Ⅱ | Erasmus University | Renal cell carcinoma | Details | |
[90Y]-DOTA-cG250 | Phase Ⅰ | Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center | Renal carcinoma | Details | |
Sulfamide-nitroimidazole | Phase Not Specified | DualTPharma | Cancer | Details | |
BAY 794620 | Phase Ⅰ | Bayer | Solid tumours | Details | |
DC-Ad-GMCAIX | Phase Ⅰ | University of California at Los Angeles, Kite Pharma | Renal cell carcinoma | Details | |
99mTc-MIP-1486 (Molecular Insight Pharmaceuticals) | Phase Not Specified | Progenics Pharmaceutical | Cancer | Details |
This web search service is supported by Google Inc.